🇺🇸 FDA
Patent

US 9918983

Suicidal LSD1 inhibitors targeting SOX2-expressing cancer cells

granted A61KA61K31/135A61K31/137

Quick answer

US patent 9918983 (Suicidal LSD1 inhibitors targeting SOX2-expressing cancer cells) held by THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS
Grant date
Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/135, A61K31/137, A61K31/15, A61K31/165